May 21, 2014The May 20, 2014 hearing on "Current Hospital Issues in the Medicare Program," held by the Health Subcommittee of the House Committee on Ways and Means, was the first Congressional hearing to consider the impact of … [Read more...] about Harm from Medicare’s Hospital Observation Status Debated In Congressional Hearing – Center for Medicare Advocacy Presents Beneficiary Perspective
Skilled Nursing Facility
Senior Policy Attorney Toby S. Edelman Testifies about Observation Status before Congress
Center for Medicare Advocacy Senior Policy Attorney Toby S. Edelman will testify before the House Ways and Means Health Subcommittee on Tuesday, May 20, 2014 at 9:30 AM regarding current hospital issues in the Medicare program, specifically the … [Read more...] about Senior Policy Attorney Toby S. Edelman Testifies about Observation Status before Congress
Federal Nursing Home Enforcement System is Not Punitive: Setting the Record Straight Again
The Department of Health and Human Services' Inspector General recently reported that nearly one third-of nursing home residents suffered an adverse event or other harm during a stay in a Medicare-participating nursing home in August 2011, and … [Read more...] about Federal Nursing Home Enforcement System is Not Punitive: Setting the Record Straight Again
The Myth of Improved Quality in Nursing Home Care: Setting the Record Straight Again
April 17, 2014A recent report by the Department of Health and Human Services' Inspector General found that one third-of nursing home residents in a Medicare-nursing home stay suffered an adverse event or other harm in August 2011 and that … [Read more...] about The Myth of Improved Quality in Nursing Home Care: Setting the Record Straight Again
OIG Report: Care in Skilled Nursing Facilities Harmed Nearly One-Third of Medicare Residents in August 2011
In its first analysis of adverse events in skilled nursing facilities (SNFs), the Department of Health and Human Services' Office of Inspector General (OIG) reports that care is poor and dangerous for many residents. OIG reports that nearly … [Read more...] about OIG Report: Care in Skilled Nursing Facilities Harmed Nearly One-Third of Medicare Residents in August 2011
Staffing Deficiencies in Nursing Facilities: Rarely Cited, Seldom Sanctioned
Although most nursing facilities nationwide do not have sufficient staff to provide necessary care to their residents, an analysis by the Center for Medicare Advocacy (Center) finds that the federal enforcement system cites very few facilities with … [Read more...] about Staffing Deficiencies in Nursing Facilities: Rarely Cited, Seldom Sanctioned
CMA Report: Inappropriate Use of Antipsychotic Drugs in Nursing Homes, Part Three – Recommendations to Improve the Citing of Deficiencies
As required by the 1987 federal Nursing Home Reform Law,[1] CMS has developed, tested, and periodically revised a survey protocol that state surveyors, who are generally employed by the state health departments, must use to determine nursing … [Read more...] about CMA Report: Inappropriate Use of Antipsychotic Drugs in Nursing Homes, Part Three – Recommendations to Improve the Citing of Deficiencies
CMA Report: Examining Inappropriate Use of Antipsychotic Drugs in Nursing Facilities
The misuse of antipsychotic drugs by nursing homes has been the subject of Congressional hearings and Government reports for many decades.[1] More than 300,000 nursing home residents take antipsychotic drugs and, as the Inspector General found, … [Read more...] about CMA Report: Examining Inappropriate Use of Antipsychotic Drugs in Nursing Facilities
Misuse of Antipsychotic Drugs in Nursing Homes: Are We Making Any Progress?
The recent settlement of criminal and civil charges against Johnson & Johnson for off-label marketing of Risperdal for nursing home residents once again brings the issue of antipsychotic drugs and nursing homes to public attention. A group … [Read more...] about Misuse of Antipsychotic Drugs in Nursing Homes: Are We Making Any Progress?
$2.2 Billion Johnson & Johnson Settlement Sends New Warning: Antipsychotic Drugs Should Not Be Used to Treat Dementia
November 14, 2013 For Immediate ReleaseStatement of California Advocates for Nursing Home Reform, Center for Medicare Advocacy, Legal Aid Justice Center, Long Term Care Community Coalition, The National Consumer Voice for Quality Long-Term … [Read more...] about $2.2 Billion Johnson & Johnson Settlement Sends New Warning: Antipsychotic Drugs Should Not Be Used to Treat Dementia